Satis Pharmaceutical starts accepting new customers from September 1st
Satis Pharmaceutical Co., Ltd., which is engaged in OEM business specializing in mail-order and D2C brands, will resume accepting new brand development, which had been suspended for two years, from September 1.
For the past two years, we have strengthened our manufacturing base by focusing on internal reforms in order to concentrate on the business contributions of existing customers.
Comments
Post a Comment